Dermal drug delivery : (Record no. 126975)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 05789cam a2200529Ii 4500 |
| 001 - CONTROL NUMBER | |
| control field | 9781315374215 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | FlBoTFG |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20220509192936.0 |
| 006 - FIXED-LENGTH DATA ELEMENTS--ADDITIONAL MATERIAL CHARACTERISTICS--GENERAL INFORMATION | |
| fixed length control field | m o d |
| 007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION | |
| fixed length control field | cr cnu|||unuuu |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 200130s2020 flua ob 001 0 eng d |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | OCoLC-P |
| Language of cataloging | eng |
| Description conventions | rda |
| -- | pn |
| Transcribing agency | OCoLC-P |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781315374215 |
| -- | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 1315374218 |
| -- | (electronic bk.) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781315356648 |
| -- | (electronic bk. : EPUB) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 1315356643 |
| -- | (electronic bk. : EPUB) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| Cancelled/invalid ISBN | 9781466582705 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781466582712 |
| -- | (electronic bk. : PDF) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 1466582715 |
| -- | (electronic bk. : PDF) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 9781315337586 |
| -- | (electronic bk. : Mobipocket) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| International Standard Book Number | 1315337584 |
| -- | (electronic bk. : Mobipocket) |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (OCoLC)1138019456 |
| 035 ## - SYSTEM CONTROL NUMBER | |
| System control number | (OCoLC-P)1138019456 |
| 050 #4 - LIBRARY OF CONGRESS CALL NUMBER | |
| Classification number | RM151 |
| Item number | .D47 2020eb |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MED |
| Subject category code subdivision | 017000 |
| Source | bisacsh |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MED |
| Subject category code subdivision | 071000 |
| Source | bisacsh |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | MED |
| Subject category code subdivision | 072000 |
| Source | bisacsh |
| 072 #7 - SUBJECT CATEGORY CODE | |
| Subject category code | TDCW |
| Source | bicssc |
| 082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Classification number | 615/.6 |
| Edition number | 23 |
| 245 00 - TITLE STATEMENT | |
| Title | Dermal drug delivery : |
| Remainder of title | from innovation to production / |
| Statement of responsibility, etc | edited by Tapash K. Ghosh. |
| 264 #1 - | |
| -- | Boca Raton : |
| -- | CRC Press, Taylor & Francis Group, |
| -- | [2020] |
| 264 #4 - | |
| -- | ©2020 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 1 online resource : |
| Other physical details | illustrations (some color) |
| 336 ## - | |
| -- | text |
| -- | txt |
| -- | rdacontent |
| 337 ## - | |
| -- | computer |
| -- | c |
| -- | rdamedia |
| 338 ## - | |
| -- | online resource |
| -- | cr |
| -- | rdacarrier |
| 520 ## - SUMMARY, ETC. | |
| Summary, etc | With the continued advancement of better-quality control and patient outcome reporting systems, changes in the development, control, and regulation of all pharmaceutical delivery systems including transdermal and topical products have been happening on a continuous basis. In light of various quality issues that have been reported by patients and practitioners resulting in the recall or removal of products from the market, both the pharmaceutical industries and regulatory agencies have been adopting new measures to address these issues. With chapters written by experts in this field, this book takes a 21st century multidisciplinary and cross-functional look at these dosage forms to improve the development, design, manufacturing, quality, clinical performance, safety, and regulation of these products. This book offers a wealth of up-to-date information organized in a logical sequence corresponding to various stages of research, development, and commercialization of dermal drug delivery products. The authors have been carefully selected from different sectors of pharmaceutical science for their expertise in their selected areas to present objectively a balanced view of the current state of these products development and commercialization via regulatory approval. Their insights will provide useful information to others to ensure the successful development of the next generation dermal drug products. Key Features: Presents current advancements including new technologies of transdermal and topical dosage forms. Presents challenges in the development of the new generation of transdermal and topical dosage forms. Introduces new technologies and QbD (quality by design) aspects of manufacturing and control strategies. Includes new perspectives on pre-clinical and clinical development, regulatory considerations, safety and quality. Discusses regulatory challenges, gaps, and future considerations for dermal drug delivery systems. |
| 505 0# - FORMATTED CONTENTS NOTE | |
| Formatted contents note | Chapter 1 Dermal and Transdermal Drug Delivery Systems: An Overview and Recent Advancements Kenneth A Walters & Majella E Lane Chapter 2 Preclinical and Clinical Safety and Assessment of Transdermal and Topical Dermatological Products Lindsey C. Yeh & Howard I. Maibach Chapter 3 Selection considerations for membranes and models for in-vitro/ex-vivo permeation studies Pei-Chin Tsai, Tannaz Ramezanli, Dina Wadie, Sonia Trehan, Nathaly Martos, Zheng Zhang, Bozena Michniak-Kohn Chapter 4 Design, Development, Manufacturing and Testing of Transdermal Drug Delivery Systems Timothy A. Peterson, Steven M. Wick & Chan Ko Chapter 5 Quality by Design (QbD) principles in the development of Transdermal Drug Delivery Products Muralikrishnan Angamuthu, H.N. Shivakumar & S. Narasimha Murthy Chapter 6 Microneedles for Drug Delivery: Industrial and Regulatory Perspectives Lisa A. Dick, Dan M. Dohmeier, Ann M. Purrington & Scott A. Burton Chapter 7 Biopharmaceutics Aspects of Dermally Applied Drug Delivery Systems Tapash Ghosh Chapter 8 Quality and Performance Tests for Dermal Drug Delivery Systems Margareth R.C. Marques, Tony Bennett & Gregory Fieldson Chapter 9 Perspective on Clinical Trials for Dermal Drug Delivery Systems John T. Farrar & Shamir Kalaria Chapter 10 Regulatory Standards for Approval of Topical Dermatological Drug Products April C. Braddy & Dale P. Conner Chapter 11 Gaps and Future Considerations for Development of Dermal Transdermal and Topical Delivery Systems Caroline Stransinger Chapter 12 Regulatory Challenges in Chemistry, Manufacturing and Controls: Gaps and Future Consideration for Locally Acting Topical Dermal Systems Shulin Ding Chapter 13 Development of Topical and Transdermal Dosage Forms: Regulatory Perspective Amit Mitra & Sarah A. Ibrahim Chapter 14 Innovations and Future Prospects of Dermal Delivery Systems Rashmi Upasani, Anushree Herwadkar, Neha Singh and Ajay K. Banga |
| 588 ## - | |
| -- | OCLC-licensed vendor bibliographic record. |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | MEDICAL / Dermatology |
| Source of heading or term | bisacsh |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | MEDICAL / Pharmacology |
| Source of heading or term | bisacsh |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | MEDICAL / Pharmacy |
| Source of heading or term | bisacsh |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Transdermal medication. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name as entry element | Drug delivery systems. |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ghosh, Tapash K., |
| Relator term | editor. |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Materials specified | Taylor & Francis |
| Uniform Resource Identifier | https://www.taylorfrancis.com/books/9781315374215 |
| 856 42 - ELECTRONIC LOCATION AND ACCESS | |
| Materials specified | OCLC metadata license agreement |
| Uniform Resource Identifier | http://www.oclc.org/content/dam/oclc/forms/terms/vbrl-201703.pdf |
No items available.